ja.ma/4yADKRl
ja.ma/4yADKRl
Presentation by Dr.Hirotoshi Iihara 🇯🇵 Update on CINV
REGISTER HERE TO WATCH: buff.ly/xwD5G2D
actice-changing updates in CINV (2025) 🚀
2025 marked a shift from “do antiemetics work?” to “how do we optimize care for each patient?”
Presentation by Dr.Hirotoshi Iihara 🇯🇵 Update on CINV
REGISTER HERE TO WATCH: buff.ly/xwD5G2D
actice-changing updates in CINV (2025) 🚀
2025 marked a shift from “do antiemetics work?” to “how do we optimize care for each patient?”
Presentation by Dr. Alex Chan🇺🇸 : Supportive Care Update
REGISTER HERE TO WATCH: buff.ly/xwD5G2D
Dr Alex Chan, President-Elect of MASCC discusses key recently published MASCC guidelines in his talk.
Presentation by Dr. Alex Chan🇺🇸 : Supportive Care Update
REGISTER HERE TO WATCH: buff.ly/xwD5G2D
Dr Alex Chan, President-Elect of MASCC discusses key recently published MASCC guidelines in his talk.
A warm invite to our Flagship Event: REGISTER👉 oncoalert.m-pages.com/rnaYzs/the-5...
OncoAlert, ESGO, ESSO, MASCC, SIOG & our esteemed faculty invite you to the 2026 #OncoAlertColloquium this coming february
A warm invite to our Flagship Event: REGISTER👉 oncoalert.m-pages.com/rnaYzs/the-5...
OncoAlert, ESGO, ESSO, MASCC, SIOG & our esteemed faculty invite you to the 2026 #OncoAlertColloquium this coming february
NEXT WEEK!!
FREE REGISTRATION HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
NEXT WEEK!!
FREE REGISTRATION HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
ESSO, ESGO, MASCC & SIOG
invite you to the #OncoAlertColloquium
REGISTER for FREE HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
ESSO, ESGO, MASCC & SIOG
invite you to the #OncoAlertColloquium
REGISTER for FREE HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
Register HERE
buff.ly/3CChgre
@elisabettabonzano.bsky.social
@elisaagostinetto.bsky.social
@realbowtiedoc.bsky.social
@erikahamilton9.bsky.social
@agerikssonmd.bsky.social
@drjnaidoo.bsky.social
Register HERE
buff.ly/3CChgre
@elisabettabonzano.bsky.social
@elisaagostinetto.bsky.social
@realbowtiedoc.bsky.social
@erikahamilton9.bsky.social
@agerikssonmd.bsky.social
@drjnaidoo.bsky.social
Register HERE
https://buff.ly/3CChgre
@elisabettabonzano.bsky.social
@elisaagostinetto.bsky.social
@realbowtiedoc.bsky.social
@erikahamilton9.bsky.social
@agerikssonmd.bsky.social
Register HERE
https://buff.ly/3CChgre
@elisabettabonzano.bsky.social
@elisaagostinetto.bsky.social
@realbowtiedoc.bsky.social
@erikahamilton9.bsky.social
@agerikssonmd.bsky.social
The Year in Oncology 2024 in Review
Registration is NOW OPEN:
https://buff.ly/3UW2Ice...
👆👆👆👆👆👆👆👆👆👆👆👆👆👆
We Return for our 5⃣th year and in partnership with
European Society of Surgical Oncology
European Society of Gynecological oncology
MASCC
SIOG
The Year in Oncology 2024 in Review
Registration is NOW OPEN:
https://buff.ly/3UW2Ice...
👆👆👆👆👆👆👆👆👆👆👆👆👆👆
We Return for our 5⃣th year and in partnership with
European Society of Surgical Oncology
European Society of Gynecological oncology
MASCC
SIOG
The Year in Oncology 2024 in Review
Registration is NOW OPEN:
oncoalert.m-pages.com/rnaYzs/the-5...
👆👆👆👆👆👆👆👆👆👆👆👆👆👆
We Return for our 5⃣th year and in partnership with
European Society of Surgical Oncology
European Society of Gynecological oncology
MASCC
SIOG
The Year in Oncology 2024 in Review
Registration is NOW OPEN:
oncoalert.m-pages.com/rnaYzs/the-5...
👆👆👆👆👆👆👆👆👆👆👆👆👆👆
We Return for our 5⃣th year and in partnership with
European Society of Surgical Oncology
European Society of Gynecological oncology
MASCC
SIOG
Organizaciones como @MASCC, @ASCO, @AAHPM y otras revisaron 208 estudios y lograron consenso en 58 recomendaciones.
link.springer.com/article/10.1...
Organizaciones como @MASCC, @ASCO, @AAHPM y otras revisaron 208 estudios y lograron consenso en 58 recomendaciones.
link.springer.com/article/10.1...
mascc.org/annualmeetin...
mascc.org/annualmeetin...
Score créé en Belgique (Institut Bordet) et nonobstant référence internationale pour déterminer le type de prise en charge des neutropénies fébriles chez les patients cancéreux.
Score créé en Belgique (Institut Bordet) et nonobstant référence internationale pour déterminer le type de prise en charge des neutropénies fébriles chez les patients cancéreux.